EP Patent

EP1340819A1 — Microsatellite markers

Assigned to Institut National de la Sante et de la Recherche Medicale INSERM · Expires 2003-09-03 · 23y expired

What this patent protects

The invention relates to new microsatellite markers, and their use for the evaluation of microsatellite instability in the diagnosis of tumours.

USPTO Abstract

The invention relates to new microsatellite markers, and their use for the evaluation of microsatellite instability in the diagnosis of tumours.

Drugs covered by this patent

Patent Metadata

Patent number
EP1340819A1
Jurisdiction
EP
Classification
—
Expires
2003-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.